Skip to main content
Article thumbnail
Location of Repository

Therapeutic Potential of Human Neutrophil Peptide 1 against Experimental Tuberculosis

By Sudhir Sharma, Indu Verma and G. K. Khuller

Abstract

The therapeutic efficacy of human neutrophil peptide 1 (HNP-1) against experimental tuberculosis in mice on the basis of numbers of CFU has been examined. Mice infected with 1.5 × 104 CFU of Mycobacterium tuberculosis H37Rv and treated with different doses of HNP-1 injected subcutaneously exhibited significant clearance of bacilli from lungs, livers, and spleens. There were time- and dose-dependent decreases in the bacillary load in lungs, livers, and spleens of the HNP-1-treated animals compared to that in controls (untreated animals). These observations strongly suggest the therapeutic activity of HNP-1 against tuberculosis

Topics: Biologic Response Modifiers
Publisher: American Society for Microbiology
Year: 2001
DOI identifier: 10.1128/AAC.45.2.639-640.2001
OAI identifier: oai:pubmedcentral.nih.gov:90345
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dx.doi.org/10.1128/AAC.... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.